We were invited to exhibit for the first time at the World Cancer for Thyroid Cancer in London on 16th & 17th June where we were represented by Deputy CEO Lucy Weigall and, for the first day, her first time at conference, committee member Sasha Marshom. Thank you both!
Here is Lucy’s report:
‘We were there over two days and spoke to a variety of people. What was interesting was that it was largely an international audience. Very few doctors/surgeons we spoke to were from the UK.
There was a lot of interest in what we were doing and a lot of the international endos and surgeons wanted to seek help as to how they could set up something similar, especially in smaller countries like Malta.
We spoke to several endos about the new technology coming out. There was a lot of excitement about transdermal PTH ( skin patches) and we spoke to endocrinologist Michael Sokol from the USA who expects this to be widely available within a year. We also spoke to several endocrinologists about ICG parathyroid detection which seems to be really successful. Leonardo Rangel says he uses ICG (parathyroid detection in Brazil and it’s had a massively positive effect.
We had a good chat with our advisor Prof Saba Balasubramanian, research lead at BAETS, who is running the NIFTy trial here in the UK which also uses a near infra red imaging device. Parathyroid UK are supporting this trial and its going very well. He has been talking to Parathyroid UK about becoming affiliated with BAETS and also wants to update SfE guidance on testing PTH and not just calcium in suspected parathyroid issues. He highlighted that calcium ranges vary a lot between people and what might be good for one isn’t necessarily good or safe for the other.
Overall a very good and positive experience. Always really validating hearing so much concern and so many in the medical community who want to help us.’
